Video

Dr Anthony Slonim Expounds the Growth of the ACO Coalition

Over the last 4 years, the ACO & Emerging Healthcare Delivery Coalition has continued to grow as a result of the opportunities to hear about innovations in accountable care organizations (ACOs) and to network with a diverse group of people, said Anthony Slonim, MD, DrPH, president and CEO of Renown Health and chair of the ACO Coalition.

Over the last 4 years, the ACO & Emerging Healthcare Delivery Coalition has continued to grow as a result of the opportunities to hear about innovations in accountable care organizations (ACOs) and to network with a diverse group of people, said Anthony Slonim, MD, DrPH, president and CEO of Renown Health and chair of the ACO Coalition.

Transcript

How has the ACO Coalition grown and evolved since its inception?

The ACO Coalition continues to grow. We have more members and more diverse members than we've ever had over the course of our 4 years. And I think that's a testament to what people get when they come to a meeting. They get an opportunity to hear cutting edge work that's innovative. They get to not only understand what people are doing at the research level, but how they apply it in their own ACO. And the networking opportunities are incomparable to anywhere else in the places where you go to get networking.

It's just an amazing place to be and a great opportunity to come together a couple of times a year. And to keep that momentum going, even in between the live meetings.

The ACO Coalition, while it continues to grow in size and diversity, is a place where we like to showcase innovation. So if you have innovative ideas about how you're running your ACO, or how you are advancing the health of your community or the population that you serve, bring it on. We'd love to hear about it and share it with our members.

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Matias Sanchez, MD
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo